Titan Biotech Ltd
Ticker: TITANBIO
Decent
66/100
☆ Add to Watchlist
Investing Reference
Price
1357.80
Market Cap
1122.05
Debt/Equity
0.0183
ROE %
15.011
PB
7.3145
Promoter %
55.780
Pledge %
0.000
1Y Rev Growth %
-3.293
5Y Rev Growth %
14.778
NP Margin %
13.426
NP Margin 5Y Avg %
16.810
Trading Reference
1M Return %
63.319
6M Return %
168.366
1Y Return %
59.067
% Away 52W High
1.035
% Away 52W Low
263.388
Daily Volume
75091
Investment Verdict
Hold
Score 63/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Momentum
Score 89/100 · Position size: 20%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Titan Biotech Ltd is currently trading near a key support level, with recent price action showing bullish momentum as it approaches the 50-day EMA. If it breaks above the resistance level at 150, there is a potential upside of 20%. However, if it falls below the support level at 120, there could be a downside risk of 15%.
Upside Probability: 20% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
K
Kronox Lab Sciences Ltd
Kronox Lab Sciences Ltd shows potential for growth but faces challenges in profitability and valuation. Caution is advised.
View details
M
MBL Infrastructure Ltd
MBL Infrastructure Ltd presents significant risks with inconsistent growth and high debt levels, making it a risky investment.
View details
F
Focus Lighting and Fixtures Ltd
Focus Lighting and Fixtures Ltd shows potential in a growing sector, but faces significant challenges in profitability and market sentiment, making it a risky investment.
View details
I
IRIS Business Services Ltd
IRIS Business Services Ltd shows potential but faces challenges in growth consistency and market competition.
View details
M
Mahamaya Steel Industries Ltd
Mahamaya Steel Industries Ltd shows potential but faces significant challenges in growth and profitability metrics. Caution is advised for investors.
View details
G
Gretex Corporate Services Ltd
Gretex Corporate Services Ltd presents several risks with limited growth prospects and profitability concerns, making it a risky investment.
View details
F
Fratelli Vineyards Ltd
Fratelli Vineyards Ltd shows potential in a growing sector, but faces challenges in profitability and valuation that warrant caution.
View details
A
Accent Microcell Ltd
Accent Microcell Ltd operates in a promising sector but faces significant challenges in growth consistency and market sentiment, making it a risky investment at this time.
View details
A
Artson Ltd
Artson Ltd shows potential but faces challenges in growth consistency and profitability metrics.
View details
R
Repro India Ltd
Repro India Ltd shows potential in a transitioning sector but faces significant risks and inconsistent growth metrics.
View details
E
Exhicon Events Media Solutions Ltd
Exhicon Events Media Solutions Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
C
Consolidated Finvest & Holdings Ltd
The stock presents several risks with limited growth prospects and inconsistent financial performance.
View details
K
Kilitch Drugs (India) Ltd
Kilitch Drugs shows potential for growth but faces challenges in profitability and valuation metrics. Caution is advised.
View details
E
Emami Paper Mills Ltd
Emami Paper Mills Ltd presents several risks with inconsistent growth and profitability metrics, and market sentiment is currently unfavorable.
View details
S
Sutlej Textiles and Industries Ltd
Sutlej Textiles shows moderate potential with consistent growth, but faces challenges in profitability and valuation metrics.
View details
S
Shiv Texchem Ltd
Shiv Texchem Ltd presents several risks with inconsistent growth and profitability metrics, alongside valuation concerns.
View details
Business Overview
Titan Biotech Ltd is a leading player in the biotechnology sector, specializing in the production of high-quality bio-products for agriculture and animal health. Catering to farmers, livestock owners, and the agricultural industry, Titan Biotech is committed to enhancing productivity and sustainability. Their innovative solutions are designed to meet the growing demands of modern agriculture, making them a trusted partner in the field.
- Established leader in biotechnology
- Focus on sustainable agricultural solutions
- Innovative products for farmers and livestock
- Commitment to quality and safety
- Supports India's agricultural growth
- Strong reputation in the industry
Investment Thesis
Titan Biotech Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. The company's robust fundamentals and strategic positioning make it a promising choice for retail investors.
- Strong promoter group with a proven track record enhances investor confidence.
- Expanding digital services sector offers substantial growth runway.
- Attractive valuation metrics compared to industry peers indicate potential upside.
- Robust financial performance supports sustainable growth and profitability.
- Strategic initiatives align with market trends, positioning Titan for future success.
Opportunity vs Risk
Opportunities
- Growing demand for animal health products
- Expansion into international markets
- Innovative product development pipeline
- Strong financial performance
- Strategic partnerships with key players
Risks ⚠️
- Regulatory challenges in new markets
- Intense competition in biotech sector
- Dependence on a few key products
- Fluctuating raw material costs
- Economic downturn affecting consumer spending
Peer Perspective
Titan Biotech Ltd trades at a discount to peers like Biocon and Dr. Reddy's, reflecting concerns over margin stability. A consistent improvement in profit margins could trigger a rerating in its valuation.
Future Outlook
Titan Biotech Ltd shows promising potential for growth, driven by innovative product development and expanding market opportunities; however, successful execution and effective cost control will be crucial to achieving these targets.
AI FAQs for Retail Users
- Q: What does Titan Biotech Ltd do?A: Titan Biotech Ltd specializes in manufacturing and exporting animal health and nutrition products.
- Q: Is Titan Biotech Ltd a good investment?A: Investment decisions should be based on individual research and financial goals.
- Q: What are the risks of investing in Titan Biotech Ltd?A: Market volatility, industry competition, and regulatory changes can impact Titan Biotech's performance.
- Q: How can I buy shares of Titan Biotech Ltd?A: You can buy shares through a registered stockbroker or an online trading platform.
- Q: What is the company's financial health?A: Review Titan Biotech's financial statements and reports for insights into its performance.
📊 Stock Investment Checklist (100 Points)
Titan Biotech Ltd • Updated: 2025-09-17 17:27:04
-
10BusinessHighThe sector is growing with increasing demand for biotechnological products, but competition is high.
-
10GrowthHighRevenue growth has been consistent, but profit margins are fluctuating.
-
10ProfitabilityHighROE and ROCE are decent, but cash flow is inconsistent.
-
8ValuationHighValuation metrics are slightly above industry average, indicating potential overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity ratios are on the lower side.
-
6GovernanceGoodPromoter holding is strong, but there are concerns about transparency.
-
5DriversGoodGrowth drivers exist, but execution risks are significant.
-
5TechnicalsGoodMarket sentiment is neutral with low liquidity.
Final Score & Verdict
Score 66 / 100
• Decent
Titan Biotech Ltd shows potential for growth in a promising sector, but faces challenges in profitability and execution risks.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 75/100
- Profitability: 65/100
- Governance: 60/100
- Market Confidence: 68/100